ASO-mediated knock-down of GPNMB in mutant-GRN and in Grn-deficient peripheral myeloid cells disrupts lysosomal function and immune responses

Abstract Background GPNMB has been discussed as a potential therapeutic target in GRN-mediated neurodegeneration, based on the observed reproducible upregulation in FTD-GRN cerebrospinal fluid (CSF) and post-mortem brain. However, the functional impacts of up-regulated GPNMB are currently unknown, a...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Rebecca L. Wallings, Drew A. Gillett, Hannah A. Staley, Savanna Mahn, Julian Mark, Noelle Neighbarger, Holly Kordasiewicz, Warren D. Hirst, Malú Gámez Tansey
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-04-01
Saila:	Molecular Neurodegeneration
Gaiak:	Antisense oligonucleotide Progranulin Frontotemporal dementia Neurodegeneration GPNMB Immune response
Sarrera elektronikoa:	https://doi.org/10.1186/s13024-025-00829-w
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!